BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 21803003)

  • 21. Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS).
    Roberts MS; Turner DC; Owens TS; Ramachandran A; Wetmore C; Throm SL; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():1-5. PubMed ID: 23644495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
    Andriamanana I; Gana I; Duretz B; Hulin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UPLC-MS/MS method for determination of bepotastine in human plasma.
    Choi YK; Chung YH; Nam YS; Kang DY; Kim H; Lee SE; Kim HR; Lee YS; Jeong JH
    J Chromatogr Sci; 2014 Sep; 52(8):886-93. PubMed ID: 24023058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of procarbazine in human plasma by liquid chromatography with electrospray ionization mass spectrometry.
    He X; Batchelor TT; Grossman S; Supko JG;
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):281-91. PubMed ID: 14670747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of olverembatinib in human plasma and cerebrospinal fluid by an LC-MS/MS method: Validation and clinical application.
    Xiang D; Zhao T; Wang J; Cao Y; Yu Q; Liu L; Yu H; Li X; Li N; Yi Y; Gong X
    J Pharm Biomed Anal; 2023 Jun; 230():115382. PubMed ID: 37060798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confirmatory reanalysis of incurred bioanalytical samples.
    Rocci ML; Devanarayan V; Haughey DB; Jardieu P
    AAPS J; 2007 Oct; 9(3):E336-43. PubMed ID: 18170980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
    Viswanathan CT; Bansal S; Booth B; DeStefano AJ; Rose MJ; Sailstad J; Shah VP; Skelly JP; Swann PG; Weiner R
    Pharm Res; 2007 Oct; 24(10):1962-73. PubMed ID: 17458684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid and sensitive LC/MS/MS analysis of the novel tyrosine kinase inhibitor ZD6474 in mouse plasma and tissues.
    Zirrolli JA; Bradshaw EL; Long ME; Gustafson DL
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):705-11. PubMed ID: 15935603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors.
    Holden SN; Eckhardt SG; Basser R; de Boer R; Rischin D; Green M; Rosenthal MA; Wheeler C; Barge A; Hurwitz HI
    Ann Oncol; 2005 Aug; 16(8):1391-7. PubMed ID: 15905307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.
    Ciardiello F; Caputo R; Damiano V; Caputo R; Troiani T; Vitagliano D; Carlomagno F; Veneziani BM; Fontanini G; Bianco AR; Tortora G
    Clin Cancer Res; 2003 Apr; 9(4):1546-56. PubMed ID: 12684431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
    Wedge SR; Ogilvie DJ; Dukes M; Kendrew J; Chester R; Jackson JA; Boffey SJ; Valentine PJ; Curwen JO; Musgrove HL; Graham GA; Hughes GD; Thomas AP; Stokes ES; Curry B; Richmond GH; Wadsworth PF; Bigley AL; Hennequin LF
    Cancer Res; 2002 Aug; 62(16):4645-55. PubMed ID: 12183421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of vandetanib in human plasma and cerebrospinal fluid by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS).
    Bai F; Johnson J; Wang F; Yang L; Broniscer A; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2561-6. PubMed ID: 21803003
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.